Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Chlorhexadol
2. Lora
3. 3563-58-4
4. 2-methyl-4-(2,2,2-trichloro-1-hydroxyethoxy)pentan-2-ol
5. Chloralodol [inn]
6. W8rd4n93r2
7. Mecoral
8. Chloralodol (inn)
9. Mechloral
10. Medodorm
11. Chloralodolum
12. Cloralodol
13. Cloralodol [inn-spanish]
14. Chloralodolum [inn-latin]
15. Einecs 222-634-9
16. Unii-w8rd4n93r2
17. Dea No. 2510
18. Chlorhexadol [mi]
19. Chloralodol [mart.]
20. Chloralodol [who-dd]
21. Schembl148160
22. Chembl2104116
23. Dtxsid8022795
24. Chebi:135097
25. Db01534
26. D07325
27. Q5102911
28. 2-methyl-4-[(2,2,2-trichloro-1-hydroxyethyl)oxy]pentan-2-ol
| Molecular Weight | 265.6 g/mol |
|---|---|
| Molecular Formula | C8H15Cl3O3 |
| XLogP3 | 2.1 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 264.008677 g/mol |
| Monoisotopic Mass | 264.008677 g/mol |
| Topological Polar Surface Area | 49.7 Ų |
| Heavy Atom Count | 14 |
| Formal Charge | 0 |
| Complexity | 179 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Chloral hydrate has sedative/hypnotic activity which has been shown to extend the sleep of normal made adults via a dose-response relationship. [1]
N - Nervous system
N05 - Psycholeptics
N05C - Hypnotics and sedatives
N05CC - Aldehydes and derivatives
N05CC02 - Chloralodol
ABOUT THIS PAGE
A Chlorhexadol manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Chlorhexadol, including repackagers and relabelers. The FDA regulates Chlorhexadol manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Chlorhexadol API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Chlorhexadol manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Chlorhexadol supplier is an individual or a company that provides Chlorhexadol active pharmaceutical ingredient (API) or Chlorhexadol finished formulations upon request. The Chlorhexadol suppliers may include Chlorhexadol API manufacturers, exporters, distributors and traders.
click here to find a list of Chlorhexadol suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Chlorhexadol Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Chlorhexadol GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Chlorhexadol GMP manufacturer or Chlorhexadol GMP API supplier for your needs.
A Chlorhexadol CoA (Certificate of Analysis) is a formal document that attests to Chlorhexadol's compliance with Chlorhexadol specifications and serves as a tool for batch-level quality control.
Chlorhexadol CoA mostly includes findings from lab analyses of a specific batch. For each Chlorhexadol CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Chlorhexadol may be tested according to a variety of international standards, such as European Pharmacopoeia (Chlorhexadol EP), Chlorhexadol JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Chlorhexadol USP).
LOOKING FOR A SUPPLIER?
